Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Malaria Journal
Published in: Malaria Journal 1/2013

Open Access 01-12-2013 | Research

Annotation and characterization of the Plasmodium vivax rhoptry neck protein 4 (Pv RON4)

Authors: Gabriela Arévalo-Pinzón, Hernando Curtidor, Jesica Abril, Manuel A Patarroyo

Published in: Malaria Journal | Issue 1/2013

Login to get access

Abstract

Background

The tight junction (TJ) is one of the most important structures established during merozoite invasion of host cells and a large amount of proteins stored in Toxoplasma and Plasmodium parasites’ apical organelles are involved in forming the TJ. Plasmodium falciparum and Toxoplasma gondii apical membrane antigen 1 (AMA-1) and rhoptry neck proteins (RONs) are the two main TJ components. It has been shown that RON4 plays an essential role during merozoite and sporozoite invasion to target cells. This study has focused on characterizing a novel Plasmodium vivax rhoptry protein, RON4, which is homologous to Pf RON4 and Pk RON4.

Methods

The ron4 gene was re-annotated in the P. vivax genome using various bioinformatics tools and taking Pf RON4 and Pk RON4 amino acid sequences as templates. Gene synteny, as well as identity and similarity values between open reading frames (ORFs) belonging to the three species were assessed. The gene transcription of pvron4, and the expression and localization of the encoded protein were also determined in the VCG-1 strain by molecular and immunological studies. Nucleotide and amino acid sequences obtained for pvron4 in VCG-1 were compared to those from strains coming from different geographical areas.

Results

Pv RON4 is a 733 amino acid long protein, which is encoded by three exons, having similar transcription and translation patterns to those reported for its homologue, Pf RON4. Sequencing Pv RON4 from the VCG-1 strain and comparing it to P. vivax strains from different geographical locations has shown two conserved regions separated by a low complexity variable region, possibly acting as a “smokescreen”. Pv RON4 contains a predicted signal sequence, a coiled-coil α-helical motif, two tandem repeats and six conserved cysteines towards the carboxy-terminus and is a soluble protein lacking predicted transmembranal domains or a GPI anchor. Indirect immunofluorescence assays have shown that Pv RON4 is expressed at the apical end of schizonts and co-localizes at the rhoptry neck with Pv RON2.

Conclusions

Genomic, transcriptional and expression data reported for Pv RON4, as well as its primary structure characteristics suggest that this protein participates in reticulocyte invasion, as has been shown for its homologue Pf RON4.
Appendix
Available only for authorised users
Literature
1.
WHO: World malaria report. 2011, Geneva: WHO Press
2.
Price RN, Tjitra E, Guerra CA, Yeung S, White NJ, Anstey NM: Vivax malaria: neglected and not benign. Am J Trop Med Hyg. 2007, 77: 79-87.PubMedCentralPubMed
3.
Beg MA, Khan R, Baig SM, Gulzar Z, Hussain R, Smego RA: Cerebral involvement in benign tertian malaria. Am J Trop Med Hyg. 2002, 67: 230-232.PubMed
4.
Anstey NM, Russell B, Yeo TW, Price RN: The pathophysiology of vivax malaria. Trends Parasitol. 2009, 25: 220-227. 10.1016/j.pt.2009.02.003.CrossRefPubMed
5.
6.
Noulin F, Borlon C, Van Den Abbeele J, D’Alessandro U, Erhart A: 1912-2012: a century of research on Plasmodium vivax in vitro culture. Trends Parasitol. 2013, 29: 286-294. 10.1016/j.pt.2013.03.012.CrossRefPubMed
7.
Pico De Coana Y, Rodriguez J, Guerrero E, Barrero C, Rodriguez R, Mendoza M, Patarroyo MA: A highly infective Plasmodium vivax strain adapted to Aotus monkeys: quantitative haematological and molecular determinations useful for P. vivax malaria vaccine development. Vaccine. 2003, 21: 3930-3937. 10.1016/S0264-410X(03)00278-0.CrossRefPubMed
8.
Arevalo-Pinzon G, Curtidor H, Patino LC, Patarroyo MA: PvRON2, a new Plasmodium vivax rhoptry neck antigen. Malar J. 2011, 10: 60-10.1186/1475-2875-10-60.PubMedCentralCrossRefPubMed
9.
Mongui A, Perez-Leal O, Rojas-Caraballo J, Angel DI, Cortes J, Patarroyo MA: Identifying and characterising the Plasmodium falciparum RhopH3 Plasmodium vivax homologue. Biochem Biophys Res Commun. 2007, 358: 861-866. 10.1016/j.bbrc.2007.05.015.CrossRefPubMed
10.
Moreno-Perez DA, Areiza-Rojas R, Florez-Buitrago X, Silva Y, Patarroyo ME, Patarroyo MA: The GPI-anchored 6-Cys protein Pv12 is present in detergent-resistant microdomains of Plasmodium vivax blood stage schizonts. Protist. 2013, 164: 37-48. 10.1016/j.protis.2012.03.001.CrossRefPubMed
11.
Moreno-Perez DA, Mongui A, Soler LN, Sanchez-Ladino M, Patarroyo MA: Identifying and characterizing a member of the RhopH1/Clag family in Plasmodium vivax. Gene. 2011, 481: 17-23. 10.1016/j.gene.2011.03.007.CrossRefPubMed
12.
Cowman AF, Berry D, Baum J: The cellular and molecular basis for malaria parasite invasion of the human red blood cell. J Cell Biol. 2012, 198: 961-971. 10.1083/jcb.201206112.PubMedCentralCrossRefPubMed
13.
Baum J, Gilberger TW, Frischknecht F, Meissner M: Host-cell invasion by malaria parasites: insights from Plasmodium and Toxoplasma. Trends Parasitol. 2008, 24: 557-563. 10.1016/j.pt.2008.08.006.CrossRefPubMed
14.
Nichols BA, Chiappino ML, O’Connor GR: Secretion from the rhoptries of Toxoplasma gondii during host-cell invasion. J Ultrastruct Res. 1983, 83: 85-98. 10.1016/S0022-5320(83)90067-9.CrossRefPubMed
15.
Stewart MJ, Schulman S, Vanderberg JP: Rhoptry secretion of membranous whorls by Plasmodium falciparum merozoites. Am J Trop Med Hyg. 1986, 35: 37-44.PubMed
16.
Bradley PJ, Ward C, Cheng SJ, Alexander DL, Coller S, Coombs GH, Dunn JD, Ferguson DJ, Sanderson SJ, Wastling JM, Boothroyd JC: Proteomic analysis of rhoptry organelles reveals many novel constituents for host-parasite interactions in Toxoplasma gondii. J Biol Chem. 2005, 280: 34245-34258. 10.1074/jbc.M504158200.CrossRefPubMed
17.
Cao J, Kaneko O, Thongkukiatkul A, Tachibana M, Otsuki H, Gao Q, Tsuboi T, Torii M: Rhoptry neck protein RON2 forms a complex with microneme protein AMA1 in Plasmodium falciparum merozoites. Parasitol Int. 2009, 58: 29-35. 10.1016/j.parint.2008.09.005.CrossRefPubMed
18.
Morahan BJ, Sallmann GB, Huestis R, Dubljevic V, Waller KL: Plasmodium falciparum: genetic and immunogenic characterisation of the rhoptry neck protein PfRON4. Exp Parasitol. 2009, 122: 280-288. 10.1016/j.exppara.2009.04.013.CrossRefPubMed
19.
Curtidor H, Patino LC, Arevalo-Pinzon G, Patarroyo ME, Patarroyo MA: Identification of the Plasmodium falciparum rhoptry neck protein 5 (PfRON5). Gene. 2011, 474: 22-28. 10.1016/j.gene.2010.12.005.CrossRefPubMed
20.
Collins CR, Withers-Martinez C, Hackett F, Blackman MJ: An inhibitory antibody blocks interactions between components of the malarial invasion machinery. PLoS Pathog. 2009, 5: e1000273-10.1371/journal.ppat.1000273.PubMedCentralCrossRefPubMed
21.
Vulliez-Le Normand B, Tonkin ML, Lamarque MH, Langer S, Hoos S, Roques M, Saul FA, Faber BW, Bentley GA, Boulanger MJ, Lebrun M: Structural and functional insights into the malaria parasite moving junction complex. PLoS Pathog. 2012, 8: e1002755-10.1371/journal.ppat.1002755.PubMedCentralCrossRefPubMed
22.
Srinivasan P, Beatty WL, Diouf A, Herrera R, Ambroggio X, Moch JK, Tyler JS, Narum DL, Pierce SK, Boothroyd JC, Haynes JD, Miller LH: Binding of Plasmodium merozoite proteins RON2 and AMA1 triggers commitment to invasion. Proc Natl Acad Sci USA. 2011, 108: 13275-13280. 10.1073/pnas.1110303108.PubMedCentralCrossRefPubMed
23.
Lamarque M, Besteiro S, Papoin J, Roques M, Vulliez-Le Normand B, Morlon-Guyot J, Dubremetz JF, Fauquenoy S, Tomavo S, Faber BW, Kocken CH, Thomas AW, Boulanger MJ, Bentley GA, Lebrun M: The RON2-AMA1 interaction is a critical step in moving junction-dependent invasion by apicomplexan parasites. PLoS Pathog. 2011, 7: e1001276-10.1371/journal.ppat.1001276.PubMedCentralCrossRefPubMed
24.
Giovannini D, Spath S, Lacroix C, Perazzi A, Bargieri D, Lagal V, Lebugle C, Combe A, Thiberge S, Baldacci P, Tardieux I, Menard R: Independent roles of apical membrane antigen 1 and rhoptry neck proteins during host cell invasion by apicomplexa. Cell Host Microbe. 2011, 10: 591-602. 10.1016/j.chom.2011.10.012.CrossRefPubMed
25.
Riglar DT, Richard D, Wilson DW, Boyle MJ, Dekiwadia C, Turnbull L, Angrisano F, Marapana DS, Rogers KL, Whitchurch CB, Beeson JG, Cowman AF, Ralph SA, Baum J: Super-resolution dissection of coordinated events during malaria parasite invasion of the human erythrocyte. Cell Host Microbe. 2011, 9: 9-20. 10.1016/j.chom.2010.12.003.CrossRefPubMed
26.
McBride JS, Heidrich HG: Fragments of the polymorphic Mr 185,000 glycoprotein from the surface of isolated Plasmodium falciparum merozoites form an antigenic complex. Mol Biochem Parasitol. 1987, 23: 71-84. 10.1016/0166-6851(87)90189-7.CrossRefPubMed
27.
Straub KW, Cheng SJ, Sohn CS, Bradley PJ: Novel components of the Apicomplexan moving junction reveal conserved and coccidia-restricted elements. Cell Microbiol. 2009, 11: 590-603. 10.1111/j.1462-5822.2008.01276.x.PubMedCentralCrossRefPubMed
28.
Burge C, Karlin S: Prediction of complete gene structures in human genomic DNA. J Mol Biol. 1997, 268: 78-94. 10.1006/jmbi.1997.0951.CrossRefPubMed
29.
30.
Nielsen H, Engelbrecht J, Brunak S, von Heijne G: Identification of prokaryotic and eukaryotic signal peptides and prediction of their cleavage sites. Protein Eng. 1997, 10: 1-6. 10.1093/protein/10.1.1.CrossRefPubMed
31.
Kall L, Krogh A, Sonnhammer EL: An HMM posterior decoder for sequence feature prediction that includes homology information. Bioinformatics. 2005, 21 (Suppl 1): i251-257. 10.1093/bioinformatics/bti1014.CrossRefPubMed
32.
Krogh A, Larsson B, von Heijne G, Sonnhammer EL: Predicting transmembrane protein topology with a hidden Markov model: application to complete genomes. J Mole Biol. 2001, 305: 567-580. 10.1006/jmbi.2000.4315.CrossRef
33.
34.
Letunic I, Goodstadt L, Dickens NJ, Doerks T, Schultz J, Mott R, Ciccarelli F, Copley RR, Ponting CP, Bork P: Recent improvements to the SMART domain-based sequence annotation resource. Nucleic Acids Res. 2002, 30: 242-244. 10.1093/nar/30.1.242.PubMedCentralCrossRefPubMed
35.
Chomczynski P: A reagent for the single-step simultaneous isolation of RNA, DNA and proteins from cell and tissue samples. Biotechniques. 1993, 15: 532-534. 536-537PubMed
36.
Moreno-Perez DA, Montenegro M, Patarroyo ME, Patarroyo MA: Identification, characterization and antigenicity of the Plasmodium vivax rhoptry neck protein 1 (PvRON1). Malar J. 2011, 10: 314-10.1186/1475-2875-10-314.PubMedCentralCrossRefPubMed
37.
Neafsey DE, Galinsky K, Jiang RH, Young L, Sykes SM, Saif S, Gujja S, Goldberg JM, Young S, Zeng Q, Chapman SB, Dash AP, Anvikar AR, Sutton PL, Birren BW, Escalante AA, Barnwell JW, Carlton JM: The malaria parasite Plasmodium vivax exhibits greater genetic diversity than Plasmodium falciparum. Nat Genet. 2012, 44: 1046-1050. 10.1038/ng.2373.PubMedCentralCrossRefPubMed
38.
Thompson JD, Higgins DG, Gibson TJ: CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res. 1994, 22: 4673-4680. 10.1093/nar/22.22.4673.PubMedCentralCrossRefPubMed
39.
Geourjon C, Deleage G, Roux B: ANTHEPROT: an interactive graphics software for analyzing protein structures from sequences. J Mol Graph. 1991, 9: 188-190. 10.1016/0263-7855(91)80008-N. 167CrossRefPubMed
40.
41.
Escalante AA, Ayala FJ: Phylogeny of the malarial genus Plasmodium, derived from rRNA gene sequences. Proc Natl Acad Sci USA. 1994, 91: 11373-11377. 10.1073/pnas.91.24.11373.PubMedCentralCrossRefPubMed
42.
Bozdech Z, Llinas M, Pulliam BL, Wong ED, Zhu J, DeRisi JL: The transcriptome of the intraerythrocytic developmental cycle of Plasmodium falciparum. PLoS Biol. 2003, 1: E5-PubMedCentralCrossRefPubMed
43.
Florens L, Washburn MP, Raine JD, Anthony RM, Grainger M, Haynes JD, Moch JK, Muster N, Sacci JB, Tabb DL, Witney AA, Wolters D, Wu Y, Gardner MJ, Holder AA, Sinden RE, Yates JR, Carucci DJ: A proteomic view of the Plasmodium falciparum life cycle. Nature. 2002, 419: 520-526. 10.1038/nature01107.CrossRefPubMed
44.
Dame JB, Williams JL, McCutchan TF, Weber JL, Wirtz RA, Hockmeyer WT, Maloy WL, Haynes JD, Schneider I, Roberts D, Sanders GS, Reddy EP, Diggs CL, Miller LH: Structure of the gene encoding the immunodominant surface antigen on the sporozoite of the human malaria parasite Plasmodium falciparum. Science. 1984, 225: 593-599. 10.1126/science.6204383.CrossRefPubMed
45.
Fenton B, Walker A, Walliker D: Protein variation in clones of Plasmodium falciparum detected by two dimensional electrophoresis. Mol Biochem Parasitol. 1985, 16: 173-183. 10.1016/0166-6851(85)90085-4.CrossRefPubMed
46.
Hisaeda H, Yasutomo K, Himeno K: Malaria: immune evasion by parasites. Int J Biochem Cell Biol. 2005, 37: 700-706. 10.1016/j.biocel.2004.10.009.CrossRefPubMed
47.
Besteiro S, Michelin A, Poncet J, Dubremetz JF, Lebrun M: Export of a Toxoplasma gondii rhoptry neck protein complex at the host cell membrane to form the moving junction during invasion. PLoS Pathog. 2009, 5: e1000309-10.1371/journal.ppat.1000309.PubMedCentralCrossRefPubMed
48.
Proellocks NI, Coppel RL, Waller KL: Dissecting the apicomplexan rhoptry neck proteins. Trends Parasitol. 2010, 26: 297-304. 10.1016/j.pt.2010.02.012.CrossRefPubMed
49.
Kauth CW, Woehlbier U, Kern M, Mekonnen Z, Lutz R, Mucke N, Langowski J, Bujard H: Interactions between merozoite surface proteins 1, 6, and 7 of the malaria parasite Plasmodium falciparum. J Biol Chem. 2006, 281: 31517-31527. 10.1074/jbc.M604641200.CrossRefPubMed
50.
Pachebat JA, Kadekoppala M, Grainger M, Dluzewski AR, Gunaratne RS, Scott-Finnigan TJ, Ogun SA, Ling IT, Bannister LH, Taylor HM, Mitchell GH, Holder AA: Extensive proteolytic processing of the malaria parasite merozoite surface protein 7 during biosynthesis and parasite release from erythrocytes. Mol Biochem Parasitol. 2007, 151: 59-69. 10.1016/j.molbiopara.2006.10.006.CrossRefPubMed
51.
Lebrun M, Michelin A, El Hajj H, Poncet J, Bradley PJ, Vial H, Dubremetz JF: The rhoptry neck protein RON4 re-localizes at the moving junction during Toxoplasma gondii invasion. Cell Microbiol. 2005, 7: 1823-1833. 10.1111/j.1462-5822.2005.00646.x.CrossRefPubMed
Metadata
Title
Annotation and characterization of the Plasmodium vivax rhoptry neck protein 4 (Pv RON4)
Authors
Gabriela Arévalo-Pinzón
Hernando Curtidor
Jesica Abril
Manuel A Patarroyo
Publication date
01-12-2013
Publisher
BioMed Central
Published in
Malaria Journal / Issue 1/2013
Electronic ISSN: 1475-2875
DOI
https://doi.org/10.1186/1475-2875-12-356

Other articles of this Issue 1/2013

Malaria Journal 1/2013 Go to the issue

Research

Serum lipids and lipoproteins in malaria - a systematic review and meta-analysis

Research

Spatial distribution of G6PD deficiency variants across malaria-endemic regions

Research

Use of a colorimetric (DELI) test for the evaluation of chemoresistance of Plasmodium falciparum and Plasmodium vivax to commonly used anti-plasmodial drugs in the Brazilian Amazon

Research

Host immune constraints on malaria transmission: insights from population biology of within-host parasites

Research

Water vapour is a pre-oviposition attractant for the malaria vector Anopheles gambiae sensu stricto

Research

Malaria and protective behaviours: is there a malaria trap?
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits